Your browser doesn't support javascript.
loading
Serum neprilysin and the risk of death in patients with out-of-hospital cardiac arrest of non-traumatic origin.
Zelniker, Thomas A; Spaich, Sebastian; Stiepak, Jan; Steger, Florian; Katus, Hugo A; Preusch, Michael R.
Afiliação
  • Zelniker TA; Department of Cardiology, Angiology, and Pneumology, University Hospital Heidelberg, Germany.
  • Spaich S; Department of Cardiology, Angiology, and Pneumology, University Hospital Heidelberg, Germany.
  • Stiepak J; Department of Cardiology, Angiology, and Pneumology, University Hospital Heidelberg, Germany.
  • Steger F; Department of Cardiology, Angiology, and Pneumology, University Hospital Heidelberg, Germany.
  • Katus HA; Department of Cardiology, Angiology, and Pneumology, University Hospital Heidelberg, Germany.
  • Preusch MR; Department of Cardiology, Angiology, and Pneumology, University Hospital Heidelberg, Germany.
Eur Heart J Acute Cardiovasc Care ; 9(4_suppl): S169-S174, 2020 Nov.
Article em En | MEDLINE | ID: mdl-30449136
BACKGROUND: Early risk stratification remains an unmet clinical need in patients with in out-of-hospital cardiac arrest. We hypothesised that soluble neprilysin may represent a promising biomarker in patients with out-of-hospital cardiac arrest of non-traumatic origin and provide new pathobiological insight. METHODS: This pilot study was a biomarker analysis from the Heidelberg Resuscitation Registry. Serum soluble neprilysin levels on admission were measured in 144 patients with successful return of spontaneous circulation after out-of-hospital cardiac arrest of non-traumatic origin. The primary endpoint was time to all-cause mortality. KM Event Rates are reported. Cox models were adjusted for age, bystander resuscitation, initial ECG rhythm, baseline estimated glomerular filtration rate, baseline lactate, left ventricular function at baseline, and targeted temperature management. RESULTS: In total, 90 (62.5%) patients died over a follow-up of at least 30 days. Soluble neprilysin correlated weakly with high-sensitivity troponin T (r=0.18, P=0.032) but did not correlate significantly with estimated glomerular filtration rate (r=-0.12) or lactate (r=0.11). Patients with elevated soluble neprilysin levels on admission were at significantly higher risk of all-cause mortality (Q4 69.1% vs. Q1 48.4%). After multivariable adjustment, soluble neprilysin in the top quartile (Q4) was significantly associated with all-cause mortality (Q4 vs. Q1: adjusted hazard ratio 2.48 (1.20-5.12)). In an adjusted multimarker model including high-sensitivity troponin T and high-sensitivity C-reactive protein, soluble neprilysin and high-sensitivity troponin T remained independently associated with all-cause mortality (soluble neprilysin: adjusted hazard ratio 2.27 (1.08-4.78); high-sensitivity troponin T: adjusted hazard ratio 3.40 (1.63-7.09)). CONCLUSION: Soluble neprilysin, measured as early as on hospital admission, was independently associated with all-cause mortality in patients with out-of-hospital cardiac arrest of non-traumatic origin and may prove to be useful in the estimation of risk in these patients.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Neprilisina / Sistema de Registros / Medição de Risco / Parada Cardíaca Extra-Hospitalar Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Eur Heart J Acute Cardiovasc Care Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Neprilisina / Sistema de Registros / Medição de Risco / Parada Cardíaca Extra-Hospitalar Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Eur Heart J Acute Cardiovasc Care Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Alemanha